A Trial to Evaluate the Loading Dose Required to Achieve Therapeutic Serum Teicoplanin Concentration Timely
Status:
Unknown status
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the standard dosage of teicoplanin is
adequate to produce timely the trough level > 10 mg/L, which is considered to be effective in
the treatment of methicillin-resistant Staphyllococcus aureus (MRSA) bacteremia.